ArticleHeliyon2021

Anticancer activity of RAPTA-EA1 in triple-negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib.

Khwanjira Hongthong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.